DRLAX | MGLRX | DRLAX / MGLRX | |
Total Expense Ratio | 1.30 | 0.85 | 153% |
Annual Report Gross Expense Ratio | 1.77 | 0.86 | 206% |
Fund Existence | 19 years | 13 years | - |
Gain YTD | 6.683 | 3.669 | 182% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 304M | 2.22B | 14% |
Annual Yield % from dividends | 2.31 | 2.59 | 89% |
Returns for 1 year | 9.95 | 2.49 | 399% |
Returns for 3 years | 4.34 | -3.83 | -113% |
Returns for 5 years | 24.66 | 14.75 | 167% |
Returns for 10 years | 15.64 | 32.52 | 48% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HRAUX | 84.64 | 0.77 | +0.92% |
Carillon Eagle Mid Cap Growth R6 | |||
VYMRX | 16.91 | 0.14 | +0.83% |
Voya Mid Cap Research Enhanced Index C | |||
GSCLX | 31.29 | 0.19 | +0.61% |
Goldman Sachs Large Cap Gr Insghts Svc | |||
GCVUX | 24.50 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts R6 | |||
LHCVX | 18.65 | 0.05 | +0.27% |
Lord Abbett Health Care R6 |